Corporate Profile for ILEX Oncology, dated Oct. 10, 1997.--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-
Published Date: Oct. 10, 1997
Company Name: ILEX Oncology
Address: 11550 IH-10 West, Suite 300
San Antonio, TX 78230
Main Telephone
Number: 210/949-8200
Internet Home
Page Address
(URL) N/A
Chief Executive
Officer: Richard L. Love
Chief Financial
Officer: James R. Koch
Investor Relations
Contact: Ann Stevens
Business number: 210/949-8230
e-mail address: ann_stevens@ilexonc.com
Public Relations
Contact: Ann Stevens
Business number: 210/949-8230
e-mail address: ann_stevens@ilexonc.com
Trading Symbol/
Exchange: ILXO
Industry: Pharmaceutical
Market Makers: Salomon Bros. - Robert Uhl
Cowen & Co. - Ian Sanderson
Smith Barney - Michael Tong
Company description: ILEX Ilex a bush bearing berries containing saponins; cause vomiting, diarrhea. Called also holly. Oncology oncology /on·col·o·gy/ (ong-kol´ah-je) the sum of knowledge regarding tumors; the study of tumors. on·col·o·gy n. , Inc. (Nasdaq: ILXO) is dedicated to accelerating the development and commercial availability of drugs for the treatment of patients with cancer, which is the second leading cause of death in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . Since beginning operations in 1994, ILEX has focused exclusively on bringing new cancer drugs to market. Through its subsidiary ILEX Oncology Services, the Company uses its oncology drug development expertise to provide pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. with a full range of drug development services on a contract basis. ILEX believes it is the only full-service contract research organization focused solely on oncology. The Company's close association with cancer research and treatment institutions allows access to the opinion leaders and patients necessary for the efficient and timely development of oncology drugs. Through its other subsidiary, ILEX Ventures, the Company is developing a portfolio of compounds to prevent the occurrence, recurrence recurrence /re·cur·rence/ (-ker´ens) the return of symptoms after a remission.recur´rent re·cur·rence n. 1. and progression of cancer. ILEX Ventures typically enters into licensing agreements to pursue the development of these agents in partnership with pharmaceutical and biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. companies. Based in San Antonio, Texas “San Antonio” redirects here. For other uses, see San Antonio (disambiguation). San Antonio is the second most populous city in Texas, the third most populous metropolitan area in Texas, and is the seventh most populous city in the United States. As of the 2006 U.S. , ILEX Oncology has international access through its European affiliate, PFK-ILEX. CONTACT: ILEX Oncology, San Antonio San Antonio (săn ăntō`nēō, əntōn`), city (1990 pop. 935,933), seat of Bexar co., S central Tex., at the source of the San Antonio River; inc. 1837. Ann Stevens, 210/949-8230 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion